GGrantIndex
← Leaderboards

Ioannis Karakikes

Stanford University

$6,940,432
Attributed
$6,940,432
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY201225
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,940,432 · 4

By mechanism

R01$5,839,495 · 2
R00$893,241 · 1
K99$207,696 · 1

Top collaborators

No co-investigators on record.

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Cardiac

Research focus

CardiacPathogenesisHeart FailureCardiac MyocytesGenesProteinsMediatingIn VitroFunctional DisorderPhenotypeTargeted TreatmentIn VivoTranslatingSignal TransductionInduced Pluripotent Stem CellPrecision MedicineDilated CardiomyopathyMutationResponseResearch ProposalsTechnologyGenetic TranscriptionMolecularMouse Model

Grant awards (22)

Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$516,595
R01 · FY2025 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$91,843
R01 · FY2025 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$505,422
R01 · FY2024 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$91,843
R01 · FY2024 · HL · contact PI
The Role of 3-Dimensional Genome Integrity In Cardiac Laminopathies$518,496
R01 · FY2023 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$516,609
R01 · FY2023 · HL · contact PI
The Role of 3-Dimensional Genome Integrity In Cardiac Laminopathies$526,381
R01 · FY2022 · HL · contact PI
The Role of 3-Dimensional Genome Integrity In Cardiac Laminopathies$540,574
R01 · FY2021 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$392,667
R01 · FY2021 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$134,931
R01 · FY2021 · HL · contact PI
The Role of 3-Dimensional Genome Integrity In Cardiac Laminopathies$551,613
R01 · FY2020 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$392,682
R01 · FY2020 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$160,413
R01 · FY2020 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$114,020
R01 · FY2020 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$392,696
R01 · FY2019 · HL · contact PI
miR-152: A Novel Regulator of Diabetic Cardiomyopathy$320,032
R00 · FY2019 · HL · contact PI
Unraveling the pathogenesis of familial dilated cardiomyopathy towards precision medicine$392,710
R01 · FY2018 · HL · contact PI
miR-152: A Novel Regulator of Diabetic Cardiomyopathy$244,950
R00 · FY2018 · HL · contact PI
miR-152: A Novel Regulator of Diabetic Cardiomyopathy$79,260
R00 · FY2018 · HL · contact PI
miR-152: A Novel Regulator of Diabetic Cardiomyopathy$248,999
R00 · FY2017 · HL · contact PI
miR-152: A Novel Regulator of Diabetic Cardiomyopathy$103,848
K99 · FY2013 · HL · contact PI
miR-152: A Novel Regulator of Diabetic Cardiomyopathy$103,848
K99 · FY2012 · HL · contact PI